Stryker Co. (NYSE:SYK) Shares Acquired by Parkside Financial Bank & Trust

Parkside Financial Bank & Trust boosted its stake in Stryker Co. (NYSE:SYK) by 14.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 827 shares of the medical technology company’s stock after buying an additional 102 shares during the period. Parkside Financial Bank & Trust’s holdings in Stryker were worth $248,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in SYK. Marks Group Wealth Management Inc lifted its holdings in shares of Stryker by 1.1% during the fourth quarter. Marks Group Wealth Management Inc now owns 51,288 shares of the medical technology company’s stock valued at $15,359,000 after acquiring an additional 577 shares during the period. Larson Financial Group LLC increased its stake in Stryker by 15.9% during the 4th quarter. Larson Financial Group LLC now owns 10,406 shares of the medical technology company’s stock worth $3,116,000 after purchasing an additional 1,430 shares in the last quarter. Illinois Municipal Retirement Fund grew its stake in shares of Stryker by 1.9% during the 4th quarter. Illinois Municipal Retirement Fund now owns 40,077 shares of the medical technology company’s stock worth $12,001,000 after acquiring an additional 749 shares in the last quarter. RWA Wealth Partners LLC boosted its holdings in shares of Stryker by 20.6% in the 4th quarter. RWA Wealth Partners LLC now owns 7,641 shares of the medical technology company’s stock valued at $2,288,000 after buying an additional 1,303 shares during the last quarter. Finally, Sage Mountain Advisors LLC boosted its holdings in shares of Stryker by 10.7% in the 4th quarter. Sage Mountain Advisors LLC now owns 1,408 shares of the medical technology company’s stock valued at $422,000 after buying an additional 136 shares during the last quarter. Institutional investors own 77.09% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on SYK. Royal Bank of Canada increased their price objective on Stryker from $360.00 to $386.00 and gave the stock an “outperform” rating in a research report on Monday, April 15th. Citigroup boosted their price target on Stryker from $362.00 to $406.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Canaccord Genuity Group upgraded Stryker from a “hold” rating to a “buy” rating and set a $360.00 price objective for the company in a report on Wednesday, January 31st. TD Cowen boosted their price objective on Stryker from $365.00 to $400.00 and gave the stock a “buy” rating in a research report on Thursday, April 11th. Finally, StockNews.com raised Stryker from a “hold” rating to a “buy” rating in a research report on Tuesday, January 23rd. Three equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $340.67.

Insiders Place Their Bets

In other Stryker news, CAO William E. Berry, Jr. sold 7,690 shares of the company’s stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $358.48, for a total transaction of $2,756,711.20. Following the completion of the sale, the chief accounting officer now owns 3,675 shares in the company, valued at $1,317,414. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, Director Ronda E. Stryker sold 201,146 shares of the stock in a transaction on Monday, February 5th. The stock was sold at an average price of $342.90, for a total transaction of $68,972,963.40. Following the completion of the sale, the director now owns 3,755,128 shares in the company, valued at approximately $1,287,633,391.20. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CAO William E. Berry, Jr. sold 7,690 shares of the company’s stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $358.48, for a total value of $2,756,711.20. Following the completion of the transaction, the chief accounting officer now directly owns 3,675 shares in the company, valued at $1,317,414. The disclosure for this sale can be found here. Insiders sold a total of 212,109 shares of company stock worth $72,845,768 over the last 90 days. Company insiders own 5.50% of the company’s stock.

Stryker Trading Up 0.9 %

NYSE SYK traded up $3.12 during trading hours on Wednesday, hitting $338.03. 653,075 shares of the company were exchanged, compared to its average volume of 1,271,423. The stock has a market cap of $128.61 billion, a PE ratio of 40.59, a price-to-earnings-growth ratio of 2.64 and a beta of 0.89. The stock has a 50-day moving average price of $349.64 and a 200 day moving average price of $314.08. Stryker Co. has a 52 week low of $249.98 and a 52 week high of $361.41. The company has a quick ratio of 0.97, a current ratio of 1.58 and a debt-to-equity ratio of 0.59.

Stryker (NYSE:SYK) last released its earnings results on Tuesday, January 30th. The medical technology company reported $3.46 EPS for the quarter, beating analysts’ consensus estimates of $3.27 by $0.19. The firm had revenue of $5.82 billion for the quarter, compared to analysts’ expectations of $5.60 billion. Stryker had a return on equity of 22.99% and a net margin of 15.44%. The company’s quarterly revenue was up 11.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.00 earnings per share. Analysts forecast that Stryker Co. will post 11.86 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 30th. Shareholders of record on Friday, March 29th will be issued a dividend of $0.80 per share. The ex-dividend date is Wednesday, March 27th. This represents a $3.20 dividend on an annualized basis and a yield of 0.95%. Stryker’s dividend payout ratio is currently 38.79%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.